4//SEC Filing
Orlandi Cesare 4
Accession 0000899243-19-019423
CIK 0001521036other
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 4:05 PM ET
Size
23.4 KB
Accession
0000899243-19-019423
Insider Transaction Report
Form 4
Orlandi Cesare
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2019-07-08$21.10/sh+6,672$140,779→ 75,155 total - Exercise/Conversion
Common Stock
2019-07-08$21.10/sh+13,346$281,601→ 88,501 total - Exercise/Conversion
Common Stock
2019-07-08$21.10/sh+6,672$140,779→ 95,173 total - Exercise/Conversion
Stock Option (right to buy)
2019-07-08−13,346→ 0 totalExercise: $21.10Exp: 2023-03-04→ Common Stock (13,346 underlying) - Exercise/Conversion
Stock Option (right to buy)
2019-07-08−8,896→ 0 totalExercise: $18.66Exp: 2023-08-05→ Common Stock (8,896 underlying) - Exercise/Conversion
Common Stock
2019-07-08$21.10/sh+8,896$187,706→ 104,069 total - Exercise/Conversion
Stock Option (right to buy)
2019-07-08−6,672→ 0 totalExercise: $21.10From: 2018-06-25Exp: 2023-03-04→ Common Stock (6,672 underlying) - Sale
Common Stock
2019-07-08$28.33/sh−28,002$793,297→ 76,067 total - Sale
Common Stock
2019-07-08$27.60/sh−7,584$209,318→ 68,483 total - Exercise/Conversion
Stock Option (right to buy)
2019-07-08−6,672→ 0 totalExercise: $21.10Exp: 2023-03-04→ Common Stock (6,672 underlying)
Footnotes (6)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.45, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH"), any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 to $27.99, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- [F4]These options vested in four equal installments on March 4, 2014, 2015, 2016 and 2017.
- [F5]Options to purchase 13,345 shares of Common Stock were granted to the reporting person on March 4, 2013, which options were subject to vesting in up to four equal annual installments based upon the level of LNTH's satisfaction of certain performance criteria for each of fiscal years 2013, 2014, 2015 and 2016. A certain level of the performance criteria were satisfied for each of fiscal years 2013 and 2014, resulting in the partial vesting as to 6,672 shares of Common Stock.
- [F6]These options vested in four equal installments on August 5, 2014, 2015, 2016 and 2017.
Documents
Issuer
Lantheus Holdings, Inc.
CIK 0001521036
Entity typeother
Related Parties
1- filerCIK 0001610664
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 4:05 PM ET
- Size
- 23.4 KB